Case Report: Anlotinib Therapy in a Patient With Recurrent and Metastatic RAIR-DTC Harboring Coexistent TERT Promoter and BRAF(V600E) Mutations

We describe a case of recurrent and metastatic radioactive iodine-refractory differentiated thyroid cancer (RAIR-DTC) treated with anlotinib in this report. The patient was randomized to placebo initially, after disease progressed at C8 (C is the treatment cycle), the patient was referred to the ope...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Yanjun, Cheng, Shaohao, Qian, Jun, Zhang, Min, Li, Tuanli, Zhang, Ying, Diao, Chang, Zhang, Ling, Cheng, Ruochuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024690/
https://www.ncbi.nlm.nih.gov/pubmed/33842329
http://dx.doi.org/10.3389/fonc.2021.626076

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024690/
https://www.ncbi.nlm.nih.gov/pubmed/33842329
http://dx.doi.org/10.3389/fonc.2021.626076

Ejemplares similares